-
IMPACT OF KP.2 BNT162B2 COVID-19 VACCINE ON ACUTE SYMPTOMS AMONG U.S. ADULTS DURING THE 2024-2025 RESPIRATORY SEASON
Mar 18, 2026, 21:38 PM -
FROM INTENTION TO IMPLEMENTATION: A SYSTEMATIC REVIEW OF THE SOCIETAL PERSPECTIVE IN COST-EFFECTIVENESS ANALYSES OF NON-SMALL CELL LUNG CANCER THERAPIES
Mar 18, 2026, 21:38 PM -
REAL-WORLD IMPACT OF MODERN OBESITY PHARMACOTHERAPY ON LIVER OUTCOMES IN MEDICARE-ENHANCED LAB AND DEMOGRAPHICS DATA: 2021-2025
Mar 18, 2026, 21:38 PM -
PREDICTING FERTILITY INTENTIONS USING SOCIODEMOGRAPHIC AND REPRODUCTIVE FACTORS IN THE UNITED STATES: A MACHINE LEARNING APPROACH
Mar 18, 2026, 21:38 PM -
AUTOMATED TECHNICAL REPORT GENERATION FOR HEALTH ECONOMIC MODELS: A COMPARATIVE CASE STUDY OF GENERATIVE AI VS. MANUAL DEVELOPMENT
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A PATIENT-PREFERENCE-WEIGHTED SCORING ALGORITHM FOR THE QUALITY OF CARE FOR PATIENTS WITH ADVANCED ILLNESS (QCPAI) IN A MULTI-ETHNIC ASIAN SETTING
Mar 18, 2026, 21:38 PM -
VALIDATED ECONOMIC TOOL TO MEASURE THE DIRECT COSTS FOR PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION (IPAH) AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN COLOMBIA
Mar 18, 2026, 21:38 PM -
BURDEN OF LUPUS NEPHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING THE RETURN ON INVESTMENT (ROI) OF HEOR & RWE TO THE BIOPHARMACEUTICAL INDUSTRY: CASE EXAMPLE OF EXTERNAL CONTROL ARMS FOR CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
ADOPTION OF US FDA APPROVED GENE AND CELLULAR THERAPIES, 2010-2025: REAL-WORLD TRENDS USING OPTUM® MARKET CLARITY DATA
Mar 18, 2026, 21:38 PM -
IDENTIFYING DRUG REPURPOSING OPPORTUNITIES WITH AI THROUGH LITERATURE REVIEW: A STRUCTURED APPROACH FOR DETECTING NOVEL THERAPEUTIC SIGNALS IN PUBLISHED STUDIES
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING MINIMALLY INVASIVE TOTAL HYSTERECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
DIRECT ORAL ANTICOAGULANT PRESCRIBING IN PATIENTS WITH ATRIAL FIBRILLATION AND CANCER ON HOSPICE ADMISSION
Mar 18, 2026, 21:38 PM -
UTILIZING TOKENIZATION TO INTEGRATE THREE DATA SOURCES IN RARE DISEASE RESEARCH: MUSCULAR DYSTROPHY-LONGITUDINAL INTEGRATED CLAIMS (MD-LINC)
Mar 18, 2026, 21:38 PM -
WITH HIGH-DOSE INHALED CORTICOSTEROID IN PATIENTS WITH COEXISTING CHRONIC RHINOSINUSITIS WITH NASAL POLYPS AND UNCONTROLLED ASTHMA IN EVEREST
Mar 18, 2026, 21:38 PM -
THE ROLE OF SURROGACY ANALYSIS IN US AND CANADIAN HEALTH TECHNOLOGY SUBMISSIONS: A THEMATIC AND TEMPORAL REVIEW
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF AN ALGORITHM ESTIMATING CISPLATIN-BASED CHEMOTHERAPY INELIGIBILITY AMONG PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER USING REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
SOCIODEMOGRAPHIC AND COMORBIDITY FACTORS INFLUENCE MASLD RISK IN TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
MANAGEMENT OF CHILDHOOD ACUTE OTITIS MEDIA WITH OR WITHOUT ORAL ANTIBIOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
COMPARISON OF DRUG AFFORDABILITY DECISIONS ACROSS STATE-LEVEL PRESCRIPTION DRUG AFFORDABILITY BOARDS AND THE CENTERS FOR MEDICARE AND MEDICAID SERVICES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM
